Episurf Medical AB (OSTO:EPIS B)
kr 0.2415 -0.0065 (-2.62%) Market Cap: 155.22 Mil Enterprise Value: 125.32 Mil PE Ratio: 0 PB Ratio: 1.30 GF Score: 49/100

Episurf Medical AB at Redeye Medtech & Diagnostic Day Transcript

Sep 28, 2021 / 11:30AM GMT
Release Date Price: kr2.8 (-0.41%)
Oscar Bergman
Redeye AB - Analyst

We continue with our agenda here at Redeye Medtech & Diagnostics Day with our next presenting company, Episurf, with CEO Pal Ryfors. Welcome.

Pal Ryfors
Episurf Medical AB - CEO

Thank you very much. So, good afternoon, everyone. My name is Pal Ryfors. I am the CEO of Episurf Medical. I am here to provide a little bit more of an update rather than a general company presentation today, but let's get into it.

So, during the pandemic, Episurf has really developed on the clinical pipeline that we set out to develop upon a few years ago. The results that have come in are just as strong as predicted. And the launch of the Episealer Talus implant has been very successful in our opinion. COVID-19 has obviously created challenges in our commercialization. However, we've been focusing even more on regulatory work and product development work, as you will see a little bit today.

So, we are now expanding the indications for our technology. This is highly exciting. And we now have two 510(k) products in pipeline for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot